Castle Biosciences Inc.

NASDAQ: CSTL · Real-Time Price · USD
19.85
-0.24 (-1.19%)
At close: Apr 29, 2025, 3:59 PM
19.85
0.00%
After-hours: Apr 29, 2025, 04:05 PM EDT

Castle Biosciences Revenue

Castle Biosciences reported an annual revenue of $332.07M, reflecting a 51.09% growth. For the quarter ending December 31, 2024, Castle Biosciences generated $86.31M in revenue.
Revenue (ttm)
$332.07M
Revenue Growth
51.09%
Price / Sales Ratio
2.23
Revenue / Employee
$436.36K
Employees
761
Market Cap
572.57M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 332.07M +51.09%
Dec 31, 2023 219.79M +60.38%
Dec 31, 2022 137.04M +45.65%
Dec 31, 2021 94.08M +50.18%
Dec 31, 2020 62.65M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.